Literature DB >> 14715940

Extracellular signal-regulated kinase 1/2 is required for the induction of group I metabotropic glutamate receptor-mediated epileptiform discharges.

Wangfa Zhao1, Riccardo Bianchi, Min Wang, Robert K S Wong.   

Abstract

Transient stimulation of group I metabotropic glutamate receptors (mGluRs) induces persistent prolonged epileptiform discharges in hippocampal slices via a protein synthesis-dependent process. At present, the signaling process underlying the induction of these epileptiform discharges remains unknown. We examined the possible role of extracellular signal-regulated kinases (ERK1 and ERK2) because these kinases can be activated by group I mGluRs, and their activation may regulate gene expression and alter protein synthesis. The group I mGluR agonist (S)-3,5-dihydroxyphenylglycine (DHPG; 50 microm) induced activation of ERK1/2 in hippocampal slices. 2-(2-Diamino-3-methoxyphenyl-4H-1-benzopyran-4-one (PD98059) (50 microm) a specific inhibitor of mitogen-activated protein kinase kinase (MEK), suppressed ERK1/2 activation by DHPG. PD98059 or another MEK inhibitor, 1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio]butadiene (10 microm), also prevented the induction of the prolonged epileptiform discharges by DHPG. In the presence of ionotropic glutamate receptor inhibitors and tetrodotoxin (blockers), DHPG-induced epileptiform discharges were suppressed, whereas ERK1/2 activation persisted. Protein kinase C inhibitors (2-[1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl]-3-(1H-indol-3-yl) maleimide, 1 microm; or chelerythrine, 10 microm) did not prevent the generation of DHPG-induced epileptiform discharges, nor did they suppress the activation of ERK1/2 by DHPG in slices pretreated with the blockers. Genistein (30 microm), a broad-spectrum tyrosine kinase inhibitor, suppressed the DHPG-induced epileptiform discharges and the ERK1/2 activation in the presence of blockers. Induction of DHPG-mediated epileptiform discharges was also suppressed by 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-D]pyrimidine (10 microm), an Src-family tyrosine kinase inhibitor. The study shows that group I mGluRs activate ERK1/2 through a tyrosine kinase-dependent process and that this activation of ERK1/2 is necessary for the induction of prolonged epileptiform discharges in the hippocampus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14715940      PMCID: PMC6729577          DOI: 10.1523/JNEUROSCI.4515-03.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  21 in total

Review 1.  Fragile X syndrome and targeted treatment trials.

Authors:  Randi Hagerman; Julie Lauterborn; Jacky Au; Elizabeth Berry-Kravis
Journal:  Results Probl Cell Differ       Date:  2012

2.  Group I mGluR-induced epileptogenesis: distinct and overlapping roles of mGluR1 and mGluR5 and implications for antiepileptic drug design.

Authors:  Robert K S Wong; Riccardo Bianchi; Shih-Chieh Chuang; Lisa R Merlin
Journal:  Epilepsy Curr       Date:  2005 Mar-Apr       Impact factor: 7.500

3.  mGluR1/5 subtype-specific calcium signalling and induction of long-term potentiation in rat hippocampal oriens/alveus interneurones.

Authors:  Lisa Topolnik; Mounia Azzi; France Morin; André Kougioumoutzakis; Jean-Claude Lacaille
Journal:  J Physiol       Date:  2006-06-01       Impact factor: 5.182

4.  Extracellular glutamate exposure facilitates group I mGluR-mediated epileptogenesis in the hippocampus.

Authors:  Wangfa Zhao; Shih-Chieh Chuang; Steven R Young; Riccardo Bianchi; Robert K S Wong
Journal:  J Neurosci       Date:  2015-01-07       Impact factor: 6.167

5.  Unique signaling profiles of positive allosteric modulators of metabotropic glutamate receptor subtype 5 determine differences in in vivo activity.

Authors:  Jerri M Rook; Meredith J Noetzel; Wendy A Pouliot; Thomas M Bridges; Paige N Vinson; Hyekyung P Cho; Ya Zhou; Rocco D Gogliotti; Jason T Manka; Karen J Gregory; Shaun R Stauffer; F Edward Dudek; Zixiu Xiang; Colleen M Niswender; J Scott Daniels; Carrie K Jones; Craig W Lindsley; P Jeffrey Conn
Journal:  Biol Psychiatry       Date:  2012-11-07       Impact factor: 13.382

6.  miR-217-casein kinase-2 cross talk regulates ERK activation in ganglioglioma.

Authors:  Atreye Majumdar; Fahim Ahmad; Touseef Sheikh; Reshma Bhagat; Pankaj Pathak; Shanker Datt Joshi; Pankaj Seth; Vivek Tandon; Manjari Tripathi; P Saratchandra; Chitra Sarkar; Ellora Sen
Journal:  J Mol Med (Berl)       Date:  2017-08-25       Impact factor: 4.599

7.  Prolonged epileptiform discharges induced by altered group I metabotropic glutamate receptor-mediated synaptic responses in hippocampal slices of a fragile X mouse model.

Authors:  Shih-Chieh Chuang; Wangfa Zhao; Robert Bauchwitz; Qijiang Yan; Riccardo Bianchi; Robert K S Wong
Journal:  J Neurosci       Date:  2005-08-31       Impact factor: 6.167

8.  Cellular plasticity for group I mGluR-mediated epileptogenesis.

Authors:  Riccardo Bianchi; Shih-Chieh Chuang; Wangfa Zhao; Steven R Young; Robert K S Wong
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

9.  Dynamic seizure-related changes in extracellular signal-regulated kinase activation in a mouse model of temporal lobe epilepsy.

Authors:  C R Houser; C S Huang; Z Peng
Journal:  Neuroscience       Date:  2008-07-10       Impact factor: 3.590

10.  Origins of epilepsy in fragile X syndrome.

Authors:  Paul J Hagerman; Carl E Stafstrom
Journal:  Epilepsy Curr       Date:  2009 Jul-Aug       Impact factor: 7.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.